GlassScriptPhysician profile
Christopher M Phillips
NPI 1629698733
$3,675.50
in general payments reported to CMS, 2019-2025
18 companies · $2,455 in 2025
The $2,455 reported for 2025 was more than what 99% of Hospice and Palliative Medicine (Family Medicine) providers received nationally (typical 2025 total: $78.57).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,220 · 2025: $2,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,500 · Education: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,499.65 |
| Education | $175.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $590.99 | 2024-2025 | |
| Janssen Biotech, INC. | $474.81 | 2024-2025 | Tremfya |
| Genzyme Corporation | $474.78 | 2024-2025 | |
| Ucb, INC. | $425.82 | 2024-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $283.06 | 2025 | Dupixent |
| Galderma Laboratories, L.P. | $248.03 | 2024-2025 | Nemluvio |
| Amgen INC. | $222.92 | 2024-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $222.18 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $177.41 | 2025 | Sotyktu |
| Organon LLC | $103.71 | 2025 | Vtama |
| Pfizer INC. | $95.35 | 2025 | |
| Incyte Corporation | $86.31 | 2025 | Opzelura |
| Arcutis Biotherapeutics, INC. | $65.67 | 2024-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $57.56 | 2024 | |
| Strata Skin Sciences, INC. | $45.96 | 2025 | Xtrac |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $42.91 | 2024-2025 | Ycanth |
| Lnhc, INC | $30.19 | 2025 | Zelsuvmi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.84 | 2024 | Spevigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.